Emily A. Pace

988 total citations
11 papers, 777 citations indexed

About

Emily A. Pace is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Emily A. Pace has authored 11 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Emily A. Pace's work include HER2/EGFR in Cancer Research (3 papers), NF-κB Signaling Pathways (3 papers) and Natural product bioactivities and synthesis (2 papers). Emily A. Pace is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), NF-κB Signaling Pathways (3 papers) and Natural product bioactivities and synthesis (2 papers). Emily A. Pace collaborates with scholars based in United States. Emily A. Pace's co-authors include John A. Porco, Thomas D. Gilmore, Mei‐Chih Liang, Peter K. Sorger, Birgit Schoeberl, Sujata Bardhan, Chaomin Li, John G. Albeck, Kevin A. Janes and Suzanne Gaudet and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Clinical Cancer Research.

In The Last Decade

Emily A. Pace

10 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily A. Pace United States 9 501 233 143 138 117 11 777
Ribo Guo United States 14 904 1.8× 261 1.1× 80 0.6× 52 0.4× 193 1.6× 18 1.2k
Robert A. Galemmo United States 19 494 1.0× 158 0.7× 96 0.7× 40 0.3× 262 2.2× 46 1.0k
Brad O. Buckman United States 19 391 0.8× 169 0.7× 103 0.7× 75 0.5× 407 3.5× 37 986
Mark R. Witmer United States 16 378 0.8× 104 0.4× 87 0.6× 38 0.3× 116 1.0× 29 893
Ayesha Sitlani United States 18 667 1.3× 406 1.7× 120 0.8× 51 0.4× 196 1.7× 18 1.4k
Chu‐Biao Xue United States 22 577 1.2× 197 0.8× 108 0.8× 57 0.4× 320 2.7× 52 1.0k
Thomas E. Rawson United States 8 601 1.2× 262 1.1× 55 0.4× 75 0.5× 168 1.4× 17 857
Marc O’Reilly United Kingdom 15 1.0k 2.1× 219 0.9× 368 2.6× 49 0.4× 137 1.2× 20 1.3k
Ulrich Grädler Germany 17 616 1.2× 125 0.5× 45 0.3× 98 0.7× 180 1.5× 28 987
Jörg Czech Germany 16 712 1.4× 495 2.1× 76 0.5× 163 1.2× 222 1.9× 33 1.3k

Countries citing papers authored by Emily A. Pace

Since Specialization
Citations

This map shows the geographic impact of Emily A. Pace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily A. Pace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily A. Pace more than expected).

Fields of papers citing papers by Emily A. Pace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily A. Pace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily A. Pace. The network helps show where Emily A. Pace may publish in the future.

Co-authorship network of co-authors of Emily A. Pace

This figure shows the co-authorship network connecting the top 25 collaborators of Emily A. Pace. A scholar is included among the top collaborators of Emily A. Pace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily A. Pace. Emily A. Pace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Pace, Emily A., Sharlene Adams, Michael D. Curley, et al.. (2018). Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer. Clinical Cancer Research. 24(12). 2873–2885. 44 indexed citations
3.
Niepel, Mario, Marc Hafner, Emily A. Pace, et al.. (2014). Analysis of growth factor signaling in genetically diverse breast cancer lines. BMC Biology. 12(1). 20–20. 32 indexed citations
4.
Niepel, Mario, Marc Hafner, Emily A. Pace, et al.. (2013). Profiles of Basal and Stimulated Receptor Signaling Networks Predict Drug Response in Breast Cancer Lines. Science Signaling. 6(294). ra84–ra84. 73 indexed citations
5.
Schoeberl, Birgit, Emily A. Pace, Jonathan B. Fitzgerald, et al.. (2009). Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis. Science Signaling. 2(77). ra31–ra31. 275 indexed citations
6.
Liang, Mei‐Chih, Sujata Bardhan, Emily A. Pace, et al.. (2005). Inhibition of transcription factor NF-κB signaling proteins IKKβ and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity. Biochemical Pharmacology. 71(5). 634–645. 76 indexed citations
7.
Gaudet, Suzanne, Kevin A. Janes, John G. Albeck, et al.. (2005). A Compendium of Signals and Responses Triggered by Prodeath and Prosurvival Cytokines. Molecular & Cellular Proteomics. 4(10). 1569–1590. 124 indexed citations
8.
Liang, Mei‐Chih, Sujata Bardhan, Chaomin Li, et al.. (2003). Jesterone Dimer, a Synthetic Derivative of the Fungal Metabolite Jesterone, Blocks Activation of Transcription Factor Nuclear Factor κB by Inhibiting the Inhibitor of κB Kinase. Molecular Pharmacology. 64(1). 123–131. 40 indexed citations
9.
Li, Chaomin, Sujata Bardhan, Emily A. Pace, et al.. (2002). Angiogenesis Inhibitor Epoxyquinol A:  Total Synthesis and Inhibition of Transcription Factor NF-κB. Organic Letters. 4(19). 3267–3270. 64 indexed citations
10.
Li, Chaomin, Emily A. Pace, Mei‐Chih Liang, et al.. (2002). ChemInform Abstract: Total Synthesis of the NF‐ϰB Inhibitor (‐)‐Cycloepoxydon (I): Utilization of Tartrate‐Mediated Nucleophilic Epoxidation.. ChemInform. 33(14). 2 indexed citations
11.
Li, Chaomin, Emily A. Pace, Mei‐Chih Liang, et al.. (2001). Total Synthesis of the NF-κB Inhibitor (−)-Cycloepoxydon:  Utilization of Tartrate-Mediated Nucleophilic Epoxidation. Journal of the American Chemical Society. 123(45). 11308–11309. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ribo Guo Breakdown of academic impact, for papers by Robert A. Galemmo Breakdown of academic impact, for papers by Brad O. Buckman Breakdown of academic impact, for papers by Mark R. Witmer Breakdown of academic impact, for papers by Ayesha Sitlani Breakdown of academic impact, for papers by Chu‐Biao Xue Breakdown of academic impact, for papers by Thomas E. Rawson Breakdown of academic impact, for papers by Marc O’Reilly Breakdown of academic impact, for papers by Ulrich Grädler Breakdown of academic impact, for papers by Jörg Czech
Rankless by CCL
2026